| Ruxolitinib |
219660 |
002 |
NDA |
Ruxolitinib |
TABLET; ORAL |
10MG |
No
|
No
|
2025/11/21
(TA)
|
--
|
APOTEX |
None (Tentative Approval) |
| Ruxolitinib |
219660 |
003 |
NDA |
Ruxolitinib |
TABLET; ORAL |
15MG |
No
|
No
|
2025/11/21
(TA)
|
--
|
APOTEX |
None (Tentative Approval) |
| Ruxolitinib |
219660 |
004 |
NDA |
Ruxolitinib |
TABLET; ORAL |
2MG |
No
|
No
|
2025/11/21
(TA)
|
--
|
APOTEX |
None (Tentative Approval) |
| RUXOLITINIB |
220375 |
002 |
ANDA |
RUXOLITINIB |
TABLET |
20MG |
No
|
No
|
2026/03/23
(TA)
|
--
|
TORRENT PHARMACEUTICALS LTD |
None (Tentative Approval) |
| RUXOLITINIB |
220375 |
003 |
ANDA |
RUXOLITINIB |
TABLET |
15MG |
No
|
No
|
2026/03/23
(TA)
|
--
|
TORRENT PHARMACEUTICALS LTD |
None (Tentative Approval) |
| RUXOLITINIB |
220375 |
004 |
ANDA |
RUXOLITINIB |
TABLET |
10MG |
No
|
No
|
2026/03/23
(TA)
|
--
|
TORRENT PHARMACEUTICALS LTD |
None (Tentative Approval) |
| RUXOLITINIB |
220375 |
005 |
ANDA |
RUXOLITINIB |
TABLET |
5MG |
No
|
No
|
2026/03/23
(TA)
|
--
|
TORRENT PHARMACEUTICALS LTD |
None (Tentative Approval) |